GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Diagnos Inc (TSXV:ADK) » Definitions » Cyclically Adjusted Price-to-FCF

Diagnos (TSXV:ADK) Cyclically Adjusted Price-to-FCF : (As of May. 20, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Diagnos Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Diagnos Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Diagnos's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diagnos Cyclically Adjusted Price-to-FCF Chart

Diagnos Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Diagnos Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Diagnos's Cyclically Adjusted Price-to-FCF

For the Health Information Services subindustry, Diagnos's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Diagnos's Cyclically Adjusted Price-to-FCF Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Diagnos's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Diagnos's Cyclically Adjusted Price-to-FCF falls into.



Diagnos Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Diagnos's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Diagnos's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2023 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.009/125.0724*125.0724
=-0.009

Current CPI (Dec. 2023) = 125.0724.

Diagnos Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201403 -0.065 98.604 -0.082
201406 -0.117 99.473 -0.147
201409 -0.100 99.394 -0.126
201412 -0.058 98.367 -0.074
201503 -0.022 99.789 -0.028
201506 -0.040 100.500 -0.050
201509 -0.087 100.421 -0.108
201512 -0.068 99.947 -0.085
201603 -0.035 101.054 -0.043
201606 -0.045 102.002 -0.055
201609 -0.059 101.765 -0.073
201612 0.005 101.449 0.006
201703 -0.064 102.634 -0.078
201706 -0.063 103.029 -0.076
201709 -0.026 103.345 -0.031
201712 0.020 103.345 0.024
201803 -0.064 105.004 -0.076
201806 -0.008 105.557 -0.009
201809 -0.052 105.636 -0.062
201812 -0.047 105.399 -0.056
201903 -0.016 106.979 -0.019
201906 -0.021 107.690 -0.024
201909 -0.009 107.611 -0.010
201912 -0.012 107.769 -0.014
202003 -0.023 107.927 -0.027
202006 -0.007 108.401 -0.008
202009 -0.002 108.164 -0.002
202012 -0.006 108.559 -0.007
202103 -0.008 110.298 -0.009
202106 -0.008 111.720 -0.009
202109 -0.007 112.905 -0.008
202112 -0.008 113.774 -0.009
202203 -0.007 117.646 -0.007
202206 -0.009 120.806 -0.009
202209 -0.005 120.648 -0.005
202212 -0.008 120.964 -0.008
202303 -0.006 122.702 -0.006
202306 -0.009 124.203 -0.009
202309 -0.005 125.230 -0.005
202312 -0.009 125.072 -0.009

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Diagnos  (TSXV:ADK) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Diagnos Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Diagnos's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Diagnos (TSXV:ADK) Business Description

Traded in Other Exchanges
Address
7005 Taschereau Boulevard, Suite 265, Brossard, Longueuil, QC, CAN, J4Z 1A7
Diagnos Inc is engaged in the provision of software-based interpretation services to assist health specialists in the detection of diabetic retinopathy. The company provides image analysis services through CARA (Computer Assisted Retinal Analysis). It operates in the business segment of Healthcare services. The company has a business presence in Canada, the United States, UAE, Saudi Arabia, Mexico, Costa Rica, and others. The company's key revenue is derived from Canada.
Executives
Tristram Coffin 10% Security Holder

Diagnos (TSXV:ADK) Headlines

No Headlines